Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19


Circulating Tumor Cells Were Associated with the Number of T Lymphocyte Subsets and NK Cells in Peripheral Blood in Advanced Non-Small-Cell Lung Cancer.

Ye L, Zhang F, Li H, Yang L, Lv T, Gu W, Song Y.

Dis Markers. 2017;2017:5727815. doi: 10.1155/2017/5727815. Epub 2017 Dec 24.


Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile.

Löfroos AB, Kadivar M, Resic Lindehammer S, Marsal J.

Eur J Med Res. 2017 Oct 11;22(1):40. doi: 10.1186/s40001-017-0283-8.


Training the Defense System for Modern-Day Warfare: The Horizons for Immunotherapy and Vaccines for Cancer.

Kumar N, Mishra J, Quazi SH.

J immunodefic Disord. 2012 Jul 21;1(2). pii: 1000e106. No abstract available.


Can we negotiate with a tumor?

Wolfrom CM, Laurent M, Deschatrette J.

PLoS One. 2014 Aug 1;9(8):e103834. doi: 10.1371/journal.pone.0103834. eCollection 2014.


Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored.

de la Cruz-Merino L, Illescas-Vacas A, Grueso-López A, Barco-Sánchez A, Míguez-Sánchez C; Cancer Immunotherapies Spanish Group (GETICA).

Front Immunol. 2014 Mar 14;5:102. doi: 10.3389/fimmu.2014.00102. eCollection 2014. Review.


Inflammation and the two-hit hypothesis of schizophrenia.

Feigenson KA, Kusnecov AW, Silverstein SM.

Neurosci Biobehav Rev. 2014 Jan;38:72-93. doi: 10.1016/j.neubiorev.2013.11.006. Epub 2013 Nov 15. Review.


Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma.

Tosti G, Cocorocchio E, Pennacchioli E.

Clin Cosmet Investig Dermatol. 2013 Oct 17;6:245-56. doi: 10.2147/CCID.S24246. Review.


High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer.

Emerson RO, Sherwood AM, Rieder MJ, Guenthoer J, Williamson DW, Carlson CS, Drescher CW, Tewari M, Bielas JH, Robins HS.

J Pathol. 2013 Dec;231(4):433-440. doi: 10.1002/path.4260.


New insights into the role of the immune microenvironment in breast carcinoma.

de la Cruz-Merino L, Barco-Sánchez A, Henao Carrasco F, Nogales Fernández E, Vallejo Benítez A, Brugal Molina J, Martínez Peinado A, Grueso López A, Ruiz Borrego M, Codes Manuel de Villena M, Sánchez-Margalet V, Nieto-García A, Alba Conejo E, Casares Lagar N, Ibáñez Martínez J.

Clin Dev Immunol. 2013;2013:785317. doi: 10.1155/2013/785317. Epub 2013 Jun 3. Review.


Is there a role for immune checkpoint blockade with ipilimumab in prostate cancer?

Cha E, Small EJ.

Cancer Med. 2013 Apr;2(2):243-52. doi: 10.1002/cam4.64. Epub 2013 Feb 24. Review.


Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience.

Levard A, Derbel O, Méeus P, Ranchère D, Ray-Coquard I, Blay JY, Cassier PA.

BMC Cancer. 2013 Mar 11;13:109. doi: 10.1186/1471-2407-13-109.


Cancer risk in patients with Graves' disease: a nationwide cohort study.

Chen YK, Lin CL, Chang YJ, Cheng FT, Peng CL, Sung FC, Cheng YH, Kao CH.

Thyroid. 2013 Jul;23(7):879-84. doi: 10.1089/thy.2012.0568.


Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.

Mishra J, Drummond J, Quazi SH, Karanki SS, Shaw JJ, Chen B, Kumar N.

Crit Rev Oncol Hematol. 2013 Jun;86(3):232-50. doi: 10.1016/j.critrevonc.2012.09.014. Epub 2012 Oct 23. Review.


Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications.

de la Cruz-Merino L, Lejeune M, Nogales Fernández E, Henao Carrasco F, Grueso López A, Illescas Vacas A, Pulla MP, Callau C, Álvaro T.

Clin Dev Immunol. 2012;2012:756353. doi: 10.1155/2012/756353. Epub 2012 Aug 15. Review.


Immune microenvironment in colorectal cancer: a new hallmark to change old paradigms.

de la Cruz-Merino L, Henao Carrasco F, Vicente Baz D, Nogales Fernández E, Reina Zoilo JJ, Codes Manuel de Villena M, Pulido EG.

Clin Dev Immunol. 2011;2011:174149. doi: 10.1155/2011/174149. Epub 2011 Nov 24. Review.


Cancer-immune equilibrium: questions unanswered.

Bhatia A, Kumar Y.

Cancer Microenviron. 2011 Aug;4(2):209-17. doi: 10.1007/s12307-011-0065-8. Epub 2011 May 24.


Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.

Alvaro T, de la Cruz-Merino L, Henao-Carrasco F, Villar Rodríguez JL, Vicente Baz D, Codes Manuel de Villena M, Provencio M.

J Biomed Biotechnol. 2010;2010. pii: 846872. doi: 10.1155/2010/846872. Epub 2010 Aug 12. Review.


Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma.

Tripodo C, Gri G, Piccaluga PP, Frossi B, Guarnotta C, Piconese S, Franco G, Vetri V, Pucillo CE, Florena AM, Colombo MP, Pileri SA.

Am J Pathol. 2010 Aug;177(2):792-802. doi: 10.2353/ajpath.2010.091286. Epub 2010 Jul 1.


Cancer risk in patients hospitalised for Graves' disease: a population-based cohort study in Sweden.

Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K.

Br J Cancer. 2010 Apr 27;102(9):1397-9. doi: 10.1038/sj.bjc.6605624. Epub 2010 Mar 30.

Supplemental Content

Support Center